William Mullen, PA-C, MPH

Director for Real World Evidence
Indivior Medical Affairs

Poster(s):

• (275) Healthcare resource utilization and cost among commercially insured opioid use disorder patients treated with monthly injectable buprenorphine: a retrospective claims analysis
  Wednesday, October 29, 2025

• (276) Healthcare resource utilization among patients with opioid use disorder insured by Medicaid and treated with monthly injectable buprenorphine: a retrospective claims analysis
  Wednesday, October 29, 2025